Enhancement of aerobic glycolysis and suppression of mitochondrial metabolism characterize the proproliferative Warburg phenotype of cancer cells. High free tubulin in cancer cells closes voltage dependent anion channels (VDAC) to decrease mitochondrial membrane potential (DW), an effect antagonized by erastin, the canonical promotor of ferroptosis. Previously, we identified six compounds (X1-X6) that also block tubulin-dependent mitochondrial depolarization. Here, we hypothesized that VDAC opening after erastin and X1-X6 increases mitochondrial metabolism and reactive oxygen species (ROS) formation, leading to ROS-dependent mitochondrial dysfunction, bioenergetic failure and cell death. Accordingly, we characterized erastin and the two most potent structurally unrelated lead compounds, X1 and X4, on ROS formation, mitochondrial function and cell viability. Erastin, X1 and X4 increased DW followed closely by an increase in mitochondrial ROS generation within 30-60 min. Subsequently, mitochondria began to depolarize after an hour or longer indicative of mitochondrial dysfunction. Nacetylcysteine (NAC, glutathione precursor and ROS scavenger) and MitoQ (mitochondrially targeted antioxidant) blocked increased ROS formation after X1 and prevented mitochondrial dysfunction. Erastin, X1 and X4 selectively promoted cell killing in HepG2 and Huh7 human hepatocarcinoma cells compared to primary rat hepatocytes. X1 and X4-dependent cell death was blocked by NAC. These results suggest that ferroptosis induced by erastin and our erastin-like lead compounds was caused by VDAC opening, leading to increased DW, mitochondrial ROS generation and oxidative stress-induced cell death.
Introduction
Aerobic glycolysis and suppression of mitochondrial oxidative phosphorylation are characteristic features of the proproliferative Warburg metabolic phenotype [1, 2] . Tumors generate up to 90% of cellular ATP through glycolysis with the remaining being supplied by oxidative phosphorylation. By contrast, in aerobic non-proliferative cells, mitochondria contribute as much as 95% of ATP formation [3, 4] . In several types of cancer cells, glycolytic inhibition leads to increased mitochondrial metabolism and vice versa [5] [6] [7] . Compounds that inhibit glycolysis or promote mitochondrial metabolism cause tumor cell death both in vitro and in vivo [8] [9] [10] . Most research targeting cancer metabolism has https://doi.org/10.1016/j.bcp.2017.12.022 0006-2952/Ó 2018 Elsevier Inc. All rights reserved.
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focused on inhibiting glycolytic flux and much less to enhancing mitochondrial function [11, 12] . Erastin is a small molecule that causes a type of non-apoptotic, oxidative cell death called ferroptosis in Ras/Raf-mutated cancer cell lines [13] . Ferroptosis is so named because the iron chelator, desferal, prevents erastin-induced cell killing. Indeed, desferal had been shown previously to protect after a variety of oxidative stresses, including ischemia-reperfusion, drug-induced hepatotoxicity and the addition of oxidant chemicals [14] [15] [16] [17] [18] . Mechanisms of action for erastin-induced ferroptosis include inhibition of the cysteine-glutamate antiporter in the plasma membrane leading to glutathione depletion and a pro-oxidant state and inhibition of glutathione peroxidase-4 [19] . Erastin also binds to isoforms of the voltage dependent anion channels (VDAC) [20, 21] .
In mitochondria, Complexes I, III and IV of the respiratory chain pump protons from the mitochondrial matrix into the intermembrane space to create a proton motive force (Dp) comprised mostly of a mitochondrial membrane potential (DW), which drives ATP synthesis through the F 1 F O -ATP synthase (Complex V). Flux of hydrophilic metabolites into and out of mitochondria, including ATP, ADP, Pi and respiratory substrates, occurs through a variety of inner membrane carriers, but flux of these metabolites across the outer membrane occurs through a single pathway, the voltage dependent anion channel (VDAC). VDAC closure is proposed as a regulatable 'governator' of mitochondrial metabolism [22] . In planar lipid bilayers, free tubulin inhibits VDAC1 and VDAC2 but not the minor isoform VDAC3 [23, 24] . Compared to postmitotic cells, proliferating cancer cells have high levels of free tubulin for spindle formation at metaphase. As a consequence, VDAC is in a relatively closed state, which causes a global suppression of mitochondrial metabolism. Since DW formation requires influx of respiratory substrates, a decrease in free tubulin leading to VDAC opening causes an increase in DW, whereas an increase in tubulin leads to decreased DW [23, 25] .
Recently, we showed that erastin antagonizes the inhibitory effects of tubulin on VDAC. After identifying erastin as the first known pharmacological antagonist of the inhibitory effect of free tubulin on VDAC, we identified by high content cell-based screening several erastin-like small molecules that also appear to prevent VDAC closure by high free cytosolic tubulin [26] . Here, we assess the hypothesis that increased mitochondrial metabolism after VDAC opening leads to enhanced mitochondrial generation of reactive oxygen species (ROS), mitochondrial dysfunction, bioenergetic failure and cell death. We show that erastin and two structurally dissimilar erastin-like lead compounds, X1 and X4, promoted mitochondrial hyperpolarization that was followed by mitochondrial depolarization. We also determined that erastin and X1 increased mitochondrial ROS production before onset of mitochondrial depolarization. Moreover, N-acetylcysteine (NAC, glutathione precursor and ROS scavenger) and MitoQ (mitochondrially targeted antioxidant) blocked X1-induced mitochondrial ROS formation and subsequent collapse of DW. Lastly, the selective lethality of X1 and X4 to cancer cells compared to rat liver hepatocytes was prevented by NAC, as also shown previously for erastin-induced killing of Ras/ Raf-mutated cancer cells [20] . These results suggest that our erastin-like lead compounds induce non-apoptotic ''ferroptotic" death of cancer cells by reversing tubulin inhibition of VDAC, leading to elevated DW, increased mitochondrial ROS generation and oxidative stress-induced necrotic cell death. 
Materials and methods

Materials
Confocal microscopy of TMRM
To measure changes of DW, HepG2 and Huh7 cells were loaded with TMRM, as previously described [25, 27] . Briefly, 200 nM TMRM was added to cells for 30 min before replacing with 50 nM TMRM before imaging. TMRM fluorescence was imaged by a Zeiss LSM 880 NLO inverted laser scanning confocal microscope (Thornwood, NY) using a 63X 1.4 N.A. plan apochromat oil immersion lens. Fluorescence of TMRM was excited at 543 nm and detected with a Quasar multichannel spectral detector at 590-610 nm through a one Airy unit diameter pinhole. TMRM intensity was quantified using Zeiss Zen and Photoshop CS4 (Adobe Systems, San Jose, CA) software after subtraction of background fluorescence measured in the nucleus.
Measurement of reactive oxygen species
To assess cellular ROS production, cells were loaded with either cmH 2 DCFDA (10 mM) or CellROX Green (5 mM) for 30 min before imaging, concentrations that were maintained throughout the duration of experiments. cmH 2 DCFDA and CellROX Green were excited at 488 nm and emission was measured at 510-530 nm. Nonfluorescent dihydrofluoresceins react with lipid hydroperoxides and endoperoxides to generate highly fluorescent fluoresceins [28, 29] . CellRox Green (ThermoFisher) is a proprietary compound that exhibits photostable green fluorescence upon oxidation by superoxide [30] . cmDCF fluorescence was imaged exposing microscope fields only once to avoid photoactivation of the dye, whereas images of the more photostable CellROX Green images were obtained serially from the same fields before and after treatment. To assess mitochondrial superoxide production, cells were loaded with MitoSOX Red (5 mM) for 15 min before washing out [31] . MitoSOX Red was excited using a 488-nm laser and emission was measured at 560-600 nm. For all microscopy experiments, at least 4 fields were imaged at each time point in 3 independent experiments. Quantitation of fluorescence was assessed as described above for TMRM.
Cell killing
The propidium iodide (PI) cell killing assay was performed as previously described [32] . Briefly, cells plated in 24-well format were incubated in HBSS with 30 mM PI for 20 min before acquiring baseline PI fluorescence (A) using a NovoStar plate reader (BMG LABTECH GmbH, Offenburg, Germany). PI was excited at 530 nm, (25-nm band pass) and emission was measured at 590 nm (40-nm band pass). Fluorescence (X) was measured hourly. Between measurements, microtiter plates were placed in a 37°C incubator. At the end of experiments, cells were permeabilized with 100 mM digitonin for 20 min to label all nuclei with PI, and fluorescence was again measured (B). The percentage of nonviable cells (D) was calculated as D = 100(X À A)/(B À A).
Hepatocyte isolation
All animal protocols were approved by the Institutional Animal Care and Use Committee in accordance with NIH recommendations [33] . Hepatocytes were isolated from 200 to 300 g male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA), as previously described [34] . For all experiments, hepatocyte viability was !90% by trypan blue exclusion. Hepatocytes were resuspended in Waymouth's medium MB-752/1 containing 27 mM NaHCO 3 , 2 mM L-glutamine, 5% FBS, 100 nM insulin and 10 nM dexamethasone at pH 7.4. Hepatocytes were plated in 20 mg/ well collagen-coated 24-well plates at a density of 150,000 cells/ well. Hepatocytes were cultured overnight in 5% CO 2 /air at 37°C before experiments.
Statistics
Differences between groups were analyzed by Student's t-test using p < .05 as the criterion of significance. Data points are mea ns ± S.E. of 3 independent experiments with at least 4 fields surveyed per experiment. Images are representative of three or more independent experiments.
Results
3.1.
Erastin increases mitochondrial DW, promotes cellular and mitochondrial formation of reactive oxygen species and causes subsequent collapse of DW HepG2 cells were loaded with the DW indicator, TMRM, and treated with erastin (100 mM). In untreated cells, TMRM fluorescence remained unchanged for 4 h (not shown). By contrast, TMRM fluorescence increased within 1 h after treatment with erastin, signifying mitochondrial hyperpolarization, as shown previously (Fig. 1A) [23] . Subsequently after about 4 h, TMRM fluorescence began to decrease, indicating mitochondrial depolarization (Fig. 1A) . In parallel experiments, HepG2 cells were loaded with the cellular ROS indicator, chloromethyl 2 0 ,7 0 -dichlorodihydrofluor escein diacetate (cmH 2 DCF) and the mitochondrial superoxide indicator, MitoSOX Red. After 1 h exposure to erastin, cellular cmDCF and mitochondrial MitoSOX Red fluorescence increased substantially compared to vehicle-treated cells, indicating increased cellular ROS and mitochondrial superoxide formation ( Fig. 1B and C) . Increased ROS formation after erastin occurred concurrently with increased DW and preceded subsequent depolarization.
X1 and X4 promote mitochondrial hyperpolarization followed by mitochondrial depolarization in hepatocarcinoma cells
In a previous high content small molecule screening, X1 and X4 (Fig. 2) were identified as the two most potent structurally unrelated lead compounds that antagonized mitochondrial depolarization caused by high cellular free tubulin in HCC4006 lung carcinoma cells [26] . In HepG2 cells loaded with TMRM, both 10 mM X1 (Fig. 3A) and 100 mM X4 (Fig. 3B ) increased mitochondrial TMRM fluorescence, which peaked after $ 20 min and 1 h, respectively, and signified mitochondrial hyperpolarization. Following this increase in DW, TMRM diffused from mitochondria into the cytosol and nuclei beginning within1 h and 2 h after X1 and X4, respectively. Quantitative analysis confirmed that TMRM fluorescence first increased and then decreased in HepG2 cells after X1 and X4 (Fig. 3C) . Similarly, X1 and X4 promoted mitochondrial hyperpolarization followed by depolarization in Huh7 cells (Fig. 3D and images not shown) .
The mitochondrially targeted antioxidant MitoQ decreases generation of reactive oxygen species promoted by X1 in Huh7 cells
To determine whether X1 increases cellular and mitochondrial ROS, we loaded Huh7 cells with cmH 2 DCFDA. After 1 h, cmDCF fluorescence increased by $25% in untreated cells and $105% after X1 (Fig. 4A and C) . Pretreatment with the mitochondrially targeted antioxidant MitoQ (5 mM) [35] for 30 min before X1 prevented the increase in cmDCF intensity caused by X1. The increase in cmDCF fluorescence after X1 in the presence of MitoQ was nearly identical to the increase observed in vehicle-treated cells (Fig. 4A and C) . To determine if X1 promoted mitochondrial superoxide formation, we loaded Huh7 cells with the mitochondrial superoxide indicator MitoSOX Red. X1 increased MitoSOX Red fluorescence intensity by more than 200% after 1 h compared to almost no increase after vehicle treatment (Fig. 4B and D) .
N-acetylcysteine blocks X1-induced mitochondrial depolarization
To determine whether ROS contribute to mitochondrial dysfunction caused by X1, we treated cells with N-acetylcysteine (NAC, 100 mM). NAC completely blocked X1-induced mitochondrial depolarization but not the hyperpolarization (Fig. 5 A-C) . Although hyperpolarization was not blocked by NAC, the progression of increased TMRM fluorescence was somewhat slower in the presence than the absence of NAC. After X1 alone, TMRM fluorescence increased maximally after about 15 min, whereas DW increased progressively to an apparent plateau at 60 min after X1 plus NAC (Fig. 5D ).
N-acetylcysteine blocks mitochondrial and cytosolic generation of reactive oxygen species
To determine whether NAC blocks X1-induced ROS formation, we loaded Huh7 cells with the oxidative stress indicator CellROX Green and treated with X1 in the presence and absence of NAC. After X1, CellROX Green fluorescence doubled after 1 h compared to vehicle treatment, which was completely prevented by NAC ( Fig. 6A and C) . To determine whether NAC specifically blocked mitochondrial superoxide formation, MitoSOX Red fluorescence was assessed after X1 treatment in the presence and absence of NAC. X1 alone more than doubled MitoSOX Red fluorescence after 1 h compared to vehicle, which again was abrogated by NAC ( Fig. 6B and D) .
Cell killing by X1 and X4 is dose-dependent
To establish whether X1 and X4 kill cancer cells, we assessed loss of cell viability caused by X1 and X4 (0-100 mM) by PI fluorometry of HepG2 and Huh7 cells incubated in HBSS. With vehicle treatment, cell death was minimal in HepG2 (1%) and Huh7 (17%) after 12 h (Fig. 7) . In HepG2 cells, X1 at 10 and 100 mM caused $90% loss of cell viability after 12 h (Fig. 7A, left panel) . X4 was less potent and killed $60% of cells at 100 mM after 12 h (Fig. 7A, right  panel) . Huh7 cells were also more sensitive to X1 than X4, although the difference was not as great as in HepG2 cells (Fig. 7B) . Loss of viability of Huh7 cells exceeded 90% after 12 h exposure to 10 and 100 mM X1 and 100 mM X4 (Fig. 7B ). X1 at 3 mM and X4 at 30 mM had minimal effect on cell killing in both HepG2 and Huh7 cells.
N-acetylcysteine prevents cell killing by X1 and X4
To assess whether cell killing induced by X1 and X4 is ROSdependent, we assessed loss of cell viability in the presence and absence of NAC (100 mM). In HepG2 cells, X1 (10 mM) and X4 (100 mM) alone promoted 100% and 72% cell killing, respectively, after 9 h (Fig. 8) . However, pretreatment with NAC completely abolished cell killing promoted by both X1 and X4. These findings indicate that the mechanism of cell killing by X1 and X4 is ROSdependent.
X1 and X4 are selectively lethal to cancer cells
To determine if cell killing by X1 and X4 is selective to cancer cells, we treated rat hepatocytes and Huh7 cells incubated in HBSS with X1 (10 mM) and X4 (100 mM) and assessed cell killing as described above. X1-induced cell death exceeded 90% in Huh7 cells but was only $25% in rat hepatocytes after 8 h exposure to X1 (Fig. 9A) . Similarly, X4 promoted $100% cell killing in Huh7 cells after 8 h and only $20% hepatocyte killing (Fig. 9B) . These findings indicate that X1 and X4 are selectively lethal to hepatocarcinoma cells compared to hepatocytes. 
Discussion
Warburg metabolism describes a pro-proliferative phenotype where aerobic glycolysis is enhanced and mitochondrial metabolism is suppressed [1, 2] . VDAC is a dynamically modulated 'governator' of mitochondrial metabolism by which the open/closed state of VDAC regulates transport of metabolites into and out of mitochondria [22, 36] . Free dimeric tubulin, which is increased in proliferating cancer cells compared to non-proliferating cells, regulates VDAC opening and thus operates, at least in part, this governator of mitochondrial metabolism [23, 25] . Notably, the canonical inducer of ferroptosis, erastin, increases DW and reverses depolarization induced by free tubulin in cancer cells and also blocks tubulin-dependent inhibition of conductance of VDAC reconstituted into planar lipid bilayers [23] . Here, we show that mitochondrial hyperpolarization after VDAC opening leads to mitochondrial ROS formation, mitochondrial dysfunction and cytolethality. In this way, VDAC opening operates an anti-Warburg pro-oxidant switch that both reverts the pro-proliferative Warburg metabolic phenotype of aerobic glycolysis and stimulates mitochondrial ROS generation to culminate in oxidative stress-induced ferroptotic cell death [37, 38] . Thus, antagonism of tubulin-dependent VDAC closure is a pharmacological target to promote these events in cancer cells.
Recently, we completed a high-content, cell-based drug screen that identified small molecule lead compounds that reverse the inhibitory effect of free tubulin on DW similar to erastin [26] . Here, we characterized the mechanism of action by which erastin and the two most potent structurally unrelated lead compounds (X1 and X4) of our previous drug screen cause cell death. To do so, we investigated the effects of erastin, X1 and X4 (Fig. 2) on mitochondrial function and ROS production in relation to loss of cell viability.
Erastin, X1 and X4 increased DW of mitochondria, as reported previously (Figs. 1 and 3 ) [23, 26] . Since increased DW is associated with increased mitochondrial ROS generation [39, 40] , we assessed whether erastin, X1 and X4 also promoted ROS generation. Using three different fluorogenic ROS reporters, we found that erastin, X1 and X4 increased ROS generation concurrently with increased DW within 60 min or less in HepG2 and Huh7 cells (Figs. 1, 3, 4 and 6). Much of this ROS generation was mitochondrial, as indicated by the increased fluorescence of MitoSOX Red, an indicator of mitochondrial superoxide formation, and the observation that the mitochondrially targeted antioxidant (MitoQ) prevented X1-induced ROS generation (Fig. 4) . However, after longer times, DW began to decrease until complete loss of mitochondrial TMRM fluorescence occurred (Figs. 1 and 3) . After release from depolarized mitochondria, TMRM fluorescence transiently increased and appeared in nuclei and the cytosol due to electrostatic interaction of cationic TMRM with anionic nucleic acids and the reversal of concentration-dependent TMRM quenching inside mitochondria, as observed previously with rhodamine 123 during HgCl 2 -induced cell toxicity [41] .
Depolarization signified onset of mitochondrial dysfunction and loss of mitochondrial membrane integrity [42] . To further investigate the relationship of ROS production and mitochondrial dysfunction by X1, we pretreated cells with NAC, a glutathione precursor and ROS-scavenging antioxidant, before adding X1.
NAC at the relatively low concentration of 100 lM blocked mitochondrial depolarization and prevented ROS production after X1 (Figs. 5 and 6 ). Protection by NAC is consistent with the conclusion that X1-induced ROS formation was directly responsible for downstream mitochondrial dysfunction and collapse of DW. The mitochondrially targeted antioxidant MitoQ also blocked ROS generation after X1, signifying that mitochondria were the major site of ROS formation (Fig. 4) . ROS generation likely triggered mitochondrial inner membrane permeabilization by opening of mitochondrial permeability transition (MPT) pores, since the MPT blocker cyclosporin A (1 mM), which delays rather than prevents oxidant-induced mitochondrial inner membrane permeabilization, also delayed cell killing (data not shown) [43, 44] .
Previously, erastin and erastin-like anti-Warburg compounds were shown to antagonize the inhibitory effect of free tubulin on DW [23, 26] . Here, we propose that erastin, X1 and X4 stimulate mitochondrial ROS generation by opening VDAC and promoting flux of respiratory substrates and other metabolites across the mitochondrial outer membrane. These events increase DW and the reduction of respiratory redox components at ROS-generating sites to promote mitochondrial ROS formation (33;34;39) . ROS then lead to inner membrane permeabilization (MPT), collapse of DW, mitochondrial failure and cell death. Protection against mitochondrial depolarization by antioxidants like NAC and MitoQ implicates ROS and specifically mitochondrial ROS in this cascade leading to mitochondrial dysfunction and cell death.
Erastin, X1 and X4 caused loss of cell viability exceeding 65% after 8 h in a dose-dependent fashion in both HepG2 and Huh7 cells (Fig. 7) . Huh7 cells were somewhat more sensitive than HepG2 cells, particularly when treated with X1, but NAC completely protected against both X1-and X4-induced cell death (Fig. 8) . Thus, ROS generation after X1 and X4 was ultimately responsible for the cell killing. Previously, erastin was shown to be selectively lethal to cancer cells, promoting an oxidative stress-dependent form of non-apoptotic killing of Ras/Rafmutated cancer cell lines called ferroptosis [13, 20] . Similarly, X1-and X4-induced cell killing was selective to hepatocarcinoma cells as compared to primary rat hepatocytes (Fig. 9) . Erastin-induced lethality is greater in human tumor cell lines harboring mutations in HRAS, KRAS or BRAF [20] . HepG2 cells have an NRAS mutation, but Huh7 cells do not have mutations in these oncogenes [45] . Nonetheless, HepG2 and Huh7 cells were about equally vulnerable to cytotoxicity from X1 and X4 (Fig. 7) . Cell death was necrotic rather than apoptotic, since pilot studies showed that plasma membrane labeling with fluorescently tagged annexin and nuclear staining with PI occurred simultaneously, which is characteristic of necrosis (data not shown). In apoptosis by contrast, annexin labeling occurs without PI nuclear staining.
In conclusion, we characterized a novel mechanism of cell killing caused by erastin and erastin-like lead compounds in which reversal of tubulin-dependent VDAC inhibition promotes mitochondrial hyperpolarization and oxidative stress, leading to mitochondrial dysfunction, collapse of DW, and cell death. This proposed mechanism is relatively selective for cancer cells, since proliferating cancer cells require a large pool of free tubulin for spindle formation at metaphase compared to post-mitotic cells like primary hepatocytes [25] . This novel mechanism may underlie, at least in part, ferroptotic cell death. Ferroptosis after erastin has previously been attributed to inhibition of glutamate/cystine exchange leading to depletion of the antioxidant glutathione and inhibition of glutathione peroxidase-4 [13, 21] . However, cystine was not present in our cell death assay medium, which makes unlikely that cystine uptake by cystine/glutamate exchange was occurring. Future studies will be needed to determine the relative contributions of these different mechanisms to ferroptotic cell death and whether our new erastin-like lead compounds inhibit glutamate/cystine exchange or glutathione peroxidase-4. Other studies will also be needed to assess how lead compounds affect oxygen consumption, ATP/ADP ratios, and the redox status of mitochondrial NAD(P) and to determine the chemotherapeutic efficacy of VDAC openers like X1 and X4 in in vivo models of hepatic and other types of malignancy. Fig. 9 . X1 and X4 are selectively more lethal to hepatocarcinoma cells than hepatocytes. Primary rat hepatocytes and Huh7 hepatocarcinoma cells were treated with 10 mM X1 and 100 mM X4, and cell killing was assessed by PI fluorimetry. In A, Huh7 + X1 cell killing was significantly greater compared to other groups starting at 3 h. RH + X1 killing was also significant compared to RH beginning at 3 h (n = 3). In B, Huh7 + X1 cell killing was significantly greater compared to other groups starting at 6 h (n = 3). RH + X1 killing compared to RH was not significant (p > .05, n = 3).
